Because it is mainly expressed in sarcomeric muscles such as skeletal and cardiac muscles, creatine kinase M‐type is a potential diagnostic marker for myocardial infarction 67, rhabdomyolysis 68 and myositis 69. Here, CKM is linked to rhabdomyolysis.